These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 26499949)

  • 21. Prognostic significance of overexpressed long non-coding RNA TUG1 in patients with clear cell renal cell carcinoma.
    Wang PQ; Wu YX; Zhong XD; Liu B; Qiao G
    Eur Rev Med Pharmacol Sci; 2017 Jan; 21(1):82-86. PubMed ID: 28121352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis.
    Zhang Q; Geng PL; Yin P; Wang XL; Jia JP; Yao J
    Asian Pac J Cancer Prev; 2013; 14(4):2311-5. PubMed ID: 23725133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA Taurine upregulated gene 1 promotes osteosarcoma cell metastasis by mediating HIF-1α via miR-143-5p.
    Yu X; Hu L; Li S; Shen J; Wang D; Xu R; Yang H
    Cell Death Dis; 2019 Mar; 10(4):280. PubMed ID: 30911001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA taurine-up regulated gene 1 for the prognosis of osteosarcoma: A protocol for meta-analysis and bioinformatics analysis.
    Ren Z; Li C; Gan Y; Liu X; Liang F
    Medicine (Baltimore); 2021 Jun; 100(24):e26182. PubMed ID: 34128849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of long non-coding RNA taurine-upregulated gene 1 with disease conditions and prognosis, as well as its effect on cell activities in acute myeloid leukemia.
    Qin J; Bao H; Li H
    Cancer Biomark; 2018; 23(4):569-577. PubMed ID: 30452403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High expression of long non-coding RNA XIST in osteosarcoma is associated with cell proliferation and poor prognosis.
    Li GL; Wu YX; Li YM; Li J
    Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2829-2834. PubMed ID: 28682435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma.
    Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7640-7645. PubMed ID: 30536305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitronectin significantly influences prognosis in osteosarcoma.
    Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
    Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Up-regulation of long noncoding RNA CCAL predicts poor patient prognosis and promotes tumor metastasis in osteosarcoma.
    Zhou DK; Yang XW; Li H; Yang Y; Zhu ZJ; Wu N
    Int J Biol Markers; 2017 Mar; 32(1):e108-e112. PubMed ID: 28009431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of lncRNAs as prognostic biomarkers on clinical outcomes in osteosarcoma: a meta-analysis.
    Zhang W; Ren X; Qi L; Zhang C; Tu C; Li Z
    BMC Cancer; 2021 Feb; 21(1):202. PubMed ID: 33639865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma.
    Chen S; Li W; Guo A
    Biosci Rep; 2019 Apr; 39(4):. PubMed ID: 30944201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
    Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
    Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation analysis of long non-coding RNA TUG1 with disease risk, clinical characteristics, treatment response, and survival profiles of adult Ph
    Zeng P; Chai Y; You C; Yue L; Wu C; Chen H; Li L; Li J; Liu H; Zhang Y; Cao T; Li Y; Hu W
    J Clin Lab Anal; 2021 Aug; 35(8):e23583. PubMed ID: 34251066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of serum miR-124 as a biomarker for diagnosis and prognosis in osteosarcoma.
    Cong C; Wang W; Tian J; Gao T; Zheng W; Zhou C
    Cancer Biomark; 2018 Feb; 21(2):449-454. PubMed ID: 29125481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA CCAT2 enhances cell proliferation via GSK3β/β-catenin signaling pathway in human osteosarcoma.
    Ruan R; Zhao XL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):2978-2984. PubMed ID: 29863240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of serum microRNA-21 as a biomarker for chemosensitivity and prognosis in human osteosarcoma.
    Yuan J; Chen L; Chen X; Sun W; Zhou X
    J Int Med Res; 2012; 40(6):2090-7. PubMed ID: 23321165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. miR-497 as a potential serum biomarker for the diagnosis and prognosis of osteosarcoma.
    Pang PC; Shi XY; Huang WL; Sun K
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3765-3769. PubMed ID: 27735043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulated expression of long non-coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer.
    Fei ZH; Yu XJ; Zhou M; Su HF; Zheng Z; Xie CY
    Tumour Biol; 2016 Feb; 37(2):1983-93. PubMed ID: 26334618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma.
    Yao ZS; Li C; Liang D; Jiang XB; Tang JJ; Ye LQ; Yuan K; Ren H; Yang ZD; Jin DX; Zhang SC; Ding JY; Tang YC; Xu JX; Chen K; Xie WX; Guo DQ; Cui JC
    Cancer Biomark; 2018; 22(1):127-133. PubMed ID: 29630525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.